Nash Duane
- SEC CIK
- 0001591098
No open-market purchases or sales filed in the past year.
Current role at each company
- IMUX Immunic, Inc.Executive Chairmanas of Jul 18, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Nash Duane as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2021 (view filing) | Aug 10 | 1 day | Nash DuaneExecutive Chairman | PPurchase | +1.00K | $9.80 | +$9.80K | +7.1%15.0K after | |
| May 13, 2022 (view filing) | May 12 | 1 day | Nash DuaneExecutive Chairman | PPurchase | +10.0K | $5.03 | +$50.3K | +83.1%22.0K after | |
| Jun 16, 2025 (view filing) | Jun 13 | 3 days | Nash DuaneExecutive Chairman | PPurchase | +20.0K | $0.83 | +$16.6K | +124.8%36.0K after |